Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,761,239
+$1,144,968 QoQ
Shares Held
58,370
+10.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Jun 30, 2025CallValue
$483,516
CallShares
9,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. PTCT ranks #43 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in PTCT
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,761,239 | 58,370 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,616,271 | 53,079 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,726,086 | 220,196 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $14,707,257 | 239,649 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $13,666,016 | 279,812 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $483,516 | 9,900 | Call | Sole | 2026-02-27 | |
| 2025-03-31 | $6,743,994 | 132,339 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $7,396,098 | 163,848 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $779,100 | 21,000 | Call | Sole | 2026-03-31 | |
| 2024-09-30 | $779,100 | 21,000 | Put | Sole | 2026-03-31 | |
| 2024-09-30 | $6,196,145 | 167,012 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,983,846 | 64,874 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,702,401 | 92,898 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $6,981,001 | 253,302 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,196,785 | 142,650 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $4,563,783 | 112,215 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $4,121,807 | 85,091 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $5,036,378 | 131,946 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $6,629,712 | 132,066 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $956,953 | 23,888 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,031,304 | 54,444 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,813,403 | 95,742 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,211,761 | 59,440 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $661,017 | 15,638 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,099,609 | 86,581 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $6,718,059 | 110,078 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $5,360,868 | 114,671 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,959,634 | 156,871 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $4,461 | 100 | Put | Sole | 2020-05-13 | |
| 2020-03-31 | $7,813,306 | 175,147 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||